Your browser doesn't support javascript.
loading
Rivaroxaban and aspirin vs. aspirin alone in Asian compared with non-Asian patients with chronic coronary artery disease or peripheral arterial disease: the COMPASS trial.
Hori, Masatsugu; Zhu, Jun; Liang, Yan; Bhatt, Deepak L; Bosch, Jackie; Connolly, Stuart J; Fox, Keith A A; Maggioni, Aldo; Yusuf, Salim; Eikelboom, John W.
Affiliation
  • Hori M; Osaka International Cancer Institute, Osaka, Japan.
  • Zhu J; FuWai Hospital, Beijing, China.
  • Liang Y; FuWai Hospital, Beijing, China.
  • Bhatt DL; Brigham and Women's Hospital, Harvard Medical School, MA, USA.
  • Bosch J; McMaster University, Hamilton, Ontario, Canada.
  • Connolly SJ; McMaster University, Hamilton, Ontario, Canada.
  • Fox KAA; Population Health Research Institute, Hamilton, Ontario, Canada.
  • Maggioni A; Hamilton Health Sciences Hamilton, Ontario, Canada.
  • Yusuf S; Centre for Cardiovascular Science, University of Edinburgh, UK.
  • Eikelboom JW; ANMCO Research Center, Florence, Italy.
Eur Heart J ; 43(37): 3542-3552, 2022 10 07.
Article in En | MEDLINE | ID: mdl-35751528
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Aspirin / Asian People / Peripheral Arterial Disease / Rivaroxaban Limits: Humans Language: En Journal: Eur Heart J Year: 2022 Document type: Article Affiliation country: Japan Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Aspirin / Asian People / Peripheral Arterial Disease / Rivaroxaban Limits: Humans Language: En Journal: Eur Heart J Year: 2022 Document type: Article Affiliation country: Japan Country of publication: United kingdom